Shares of GemVax Technology Co., Ltd. (KOSDAQ:A041590)rose on news it is acquiring a Sweden-based biotech company. Earlier, GemVax said it was in discussions to acquire a Swedish biotech company which has proprietary rights in regenerative medicine and it will sign a contract on April 16, 2015. The company's stock price gained 5.44%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
789 KRW | +13.69% | -.--% | -21.10% |
09/04 | Flask Co., Ltd. cancelled the transaction announced on March 13, 2024 | CI |
28/03 | Motiva Korea Ltd. cancelled the acquisition of 9.5% stake in Flask Co., Ltd. from B&M Holdings. | CI |
1st Jan change | Capi. | |
---|---|---|
-21.10% | 75.14M | |
-3.74% | 1.07B | |
-30.85% | 278M | |
-37.97% | 233M | |
+8.43% | 174M | |
-43.68% | 158M | |
+8.64% | 128M | |
+10.09% | 75.08M | |
+4.46% | 55.5M |
- Stock Market
- Equities
- A041590 Stock
- News Flask Co., Ltd.
- GemVax In Talks To Acquire Swedish Biotech Company